...
snpx-img

Synaptogenix Inc, Common Stock

SNPX

NAQ

$2.94

-$0.13

(-4.23%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.07M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.2921
Volume info-icon
This is the total number of shares traded during the most recent trading day.
51.08K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.43
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.32 L
$8.78 H
$2.94

About Synaptogenix Inc, Common Stock

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSNPXSectorS&P500
1-Week Return6.33%-0.94%-2.6%
1-Month Return8.49%-5.08%-1.08%
3-Month Return-5.47%-10.62%3.45%
6-Month Return-34.23%-6.18%8.57%
1-Year Return-57.85%1.98%24.3%
3-Year Return-98.67%-0.93%25.58%
5-Year Return-96.58%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue4.38K4.87K4.97K5.71K6.35K[{"date":"2019-12-31","value":69.09,"profit":true},{"date":"2020-12-31","value":76.76,"profit":true},{"date":"2021-12-31","value":78.24,"profit":true},{"date":"2022-12-31","value":90.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(4.38K)(4.87K)(4.97K)(5.71K)(6.35K)[{"date":"2019-12-31","value":-438500,"profit":false},{"date":"2020-12-31","value":-487200,"profit":false},{"date":"2021-12-31","value":-496600,"profit":false},{"date":"2022-12-31","value":-571400,"profit":false},{"date":"2023-12-31","value":-634700,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses15.51M11.16M12.62M16.13M8.31M[{"date":"2019-12-31","value":96.15,"profit":true},{"date":"2020-12-31","value":69.14,"profit":true},{"date":"2021-12-31","value":78.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":51.53,"profit":true}]
Operating Income(15.51M)(9.46M)(12.62M)(26.36M)(8.31M)[{"date":"2019-12-31","value":-1551345700,"profit":false},{"date":"2020-12-31","value":-945641000,"profit":false},{"date":"2021-12-31","value":-1261830700,"profit":false},{"date":"2022-12-31","value":-2636099600,"profit":false},{"date":"2023-12-31","value":-831385400,"profit":false}]
Total Non-Operating Income/Expense757.41K(1.39M)14.22K10.90M3.79M[{"date":"2019-12-31","value":6.95,"profit":true},{"date":"2020-12-31","value":-12.79,"profit":false},{"date":"2021-12-31","value":0.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":34.82,"profit":true}]
Pre-Tax Income(15.13M)(12.70M)(12.61M)(5.57M)(6.04M)[{"date":"2019-12-31","value":-1513475000,"profit":false},{"date":"2020-12-31","value":-1270319700,"profit":false},{"date":"2021-12-31","value":-1261119700,"profit":false},{"date":"2022-12-31","value":-557395700,"profit":false},{"date":"2023-12-31","value":-603850400,"profit":false}]
Income Taxes(378.71K)1.55M(7.11K)(115.89K)7.74M[{"date":"2019-12-31","value":-4.89,"profit":false},{"date":"2020-12-31","value":19.98,"profit":true},{"date":"2021-12-31","value":-0.09,"profit":false},{"date":"2022-12-31","value":-1.5,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(14.76M)(14.25M)(12.60M)(5.46M)(13.78M)[{"date":"2019-12-31","value":-1475604300,"profit":false},{"date":"2020-12-31","value":-1424998400,"profit":false},{"date":"2021-12-31","value":-1260408700,"profit":false},{"date":"2022-12-31","value":-545806700,"profit":false},{"date":"2023-12-31","value":-1377927800,"profit":false}]
Income From Continuous Operations(15.13M)(12.70M)(12.61M)(5.57M)(560.19K)[{"date":"2019-12-31","value":-1513475000,"profit":false},{"date":"2020-12-31","value":-1270319700,"profit":false},{"date":"2021-12-31","value":-1261119700,"profit":false},{"date":"2022-12-31","value":-557395700,"profit":false},{"date":"2023-12-31","value":-56019000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.76M)(14.25M)(12.60M)(5.46M)(6.04M)[{"date":"2019-12-31","value":-1475604300,"profit":false},{"date":"2020-12-31","value":-1424998400,"profit":false},{"date":"2021-12-31","value":-1260408700,"profit":false},{"date":"2022-12-31","value":-545806700,"profit":false},{"date":"2023-12-31","value":-603850400,"profit":false}]
EPS (Diluted)(8.78)(13.22)(2.79)(2.07)(1.73)[{"date":"2019-12-31","value":-877.59,"profit":false},{"date":"2020-12-31","value":-1322.16,"profit":false},{"date":"2021-12-31","value":-279,"profit":false},{"date":"2022-12-31","value":-207,"profit":false},{"date":"2023-12-31","value":-173.19,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SNPX
Cash Ratio 64.74
Current Ratio 65.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNPX
ROA (LTM) -13.82%
ROE (LTM) -7.50%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SNPX
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNPX
Trailing PE 0.29
Forward PE NM
P/S (TTM) 0.00
P/B 0.31
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.28

FAQs

What is Synaptogenix Inc share price today?

Synaptogenix Inc (SNPX) share price today is $2.94

Can Indians buy Synaptogenix Inc shares?

Yes, Indians can buy shares of Synaptogenix Inc (SNPX) on Vested. To buy Synaptogenix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNPX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Synaptogenix Inc be purchased?

Yes, you can purchase fractional shares of Synaptogenix Inc (SNPX) via the Vested app. You can start investing in Synaptogenix Inc (SNPX) with a minimum investment of $1.

How to invest in Synaptogenix Inc shares from India?

You can invest in shares of Synaptogenix Inc (SNPX) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNPX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Synaptogenix Inc shares
What is Synaptogenix Inc 52-week high and low stock price?

The 52-week high price of Synaptogenix Inc (SNPX) is $8.78. The 52-week low price of Synaptogenix Inc (SNPX) is $2.32.

What is Synaptogenix Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Synaptogenix Inc (SNPX) is 0.2921

What is Synaptogenix Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Synaptogenix Inc (SNPX) is 0.31

What is Synaptogenix Inc dividend yield?

The dividend yield of Synaptogenix Inc (SNPX) is 0.00%

What is the Market Cap of Synaptogenix Inc?

The market capitalization of Synaptogenix Inc (SNPX) is $4.07M

What is Synaptogenix Inc’s stock symbol?

The stock symbol (or ticker) of Synaptogenix Inc is SNPX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top